Opinion|Videos|July 17, 2024
Treatment in Early Relapse Multiple Myeloma: Takeaways from EHA 2024
Author(s)Joseph Mikhael, MD
Dr. Mikhael discusses treatment in early relapse of multiple myeloma.
Advertisement
Episodes in this series
Video content above is prompted by the following question:
- Please discuss recent updates presented at EHA 2024 in early-relapse multiple myeloma from CARTITUDE-4, KARMMA-2, DREAMM-7, and DREAMM-8.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Health Insurance CEOs Questioned by House Committee About Rising Costs in Health Care
2
Highlighting Gaps in Allergic Rhinitis Care, Allergen Immunotherapy Access
3
Semaglutide Shows Promise for Steatohepatitis Resolution in MASH
4
Balancing Innovation With Administrative Burdens in Cancer Care
5
